TBIO
Translate Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 13th of September, 2021.
145 hedge funds and large institutions have $1.85B invested in Translate Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 55 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 30
25% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 55
Holders
145
Holding in Top 10
4
Calls
$9.87M
Puts
$9.95M
Top Buyers
| 1 | +$170M | |
| 2 | +$13.8M | |
| 3 | +$12.5M | |
| 4 |
Morgan Stanley
New York
|
+$9.76M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$6.88M |
Top Sellers
| 1 | -$72.3M | |
| 2 | -$24.7M | |
| 3 | -$15.5M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$13.8M |
| 5 |
Millennium Management
New York
|
-$6.68M |